Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	205.08	7.58	2.48
Graham Fair Price	0.00	63.44	63.44
PEG	inf	0.00	< 0.005
Price/Book	-4.32	2.19	2.28
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-4.32	1.47	1.54
Price/Sales	4.32	-5.08	-5.31
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.73	1.73
Operating Margin	0.00	-0.75	-0.75
ROA	0.00	0.24	0.24
ROE	0.37	0.37	0.00
ROIC	0.26	0.26	0.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-0.82	inf
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.50	0.00	inf
EPS QOQ	2.59	0.00	inf
FCF QOQ	1.00	0.00	inf
Revenue QOQ	-2.04	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.20	0.20	0.00
Quick Ratio	0.00	0.00	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	21.94	21.94	0.00
Cash	0.00	0.00	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	-9.44	-9.44	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.21	0.21	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.25	0.79	217.40
Naive Interpretation	Member

06 - Financial Health · Bad

Rating